GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Boule Diagnostics AB (OSTO:BOUL) » Definitions » PB Ratio

Boule Diagnostics AB (OSTO:BOUL) PB Ratio : 0.82 (As of May. 06, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Boule Diagnostics AB PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-06), Boule Diagnostics AB's share price is kr10.00. Boule Diagnostics AB's Book Value per Share for the quarter that ended in Dec. 2023 was kr12.23. Hence, Boule Diagnostics AB's PB Ratio of today is 0.82.

The historical rank and industry rank for Boule Diagnostics AB's PB Ratio or its related term are showing as below:

OSTO:BOUL' s PB Ratio Range Over the Past 10 Years
Min: 0.73   Med: 2.78   Max: 7.2
Current: 0.82

During the past 13 years, Boule Diagnostics AB's highest PB Ratio was 7.20. The lowest was 0.73. And the median was 2.78.

OSTO:BOUL's PB Ratio is ranked better than
84.89% of 794 companies
in the Medical Devices & Instruments industry
Industry Median: 2.27 vs OSTO:BOUL: 0.82

During the past 12 months, Boule Diagnostics AB's average Book Value Per Share Growth Rate was 2.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 7.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 1.70% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 8.50% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Boule Diagnostics AB was 21.70% per year. The lowest was -10.40% per year. And the median was 7.20% per year.

Back to Basics: PB Ratio


Boule Diagnostics AB PB Ratio Historical Data

The historical data trend for Boule Diagnostics AB's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boule Diagnostics AB PB Ratio Chart

Boule Diagnostics AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.98 4.29 3.20 1.27 0.92

Boule Diagnostics AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.27 0.97 0.88 0.75 0.92

Competitive Comparison of Boule Diagnostics AB's PB Ratio

For the Medical Devices subindustry, Boule Diagnostics AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boule Diagnostics AB's PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boule Diagnostics AB's PB Ratio distribution charts can be found below:

* The bar in red indicates where Boule Diagnostics AB's PB Ratio falls into.



Boule Diagnostics AB PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Boule Diagnostics AB's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=10.00/12.234
=0.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Boule Diagnostics AB  (OSTO:BOUL) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Boule Diagnostics AB PB Ratio Related Terms

Thank you for viewing the detailed overview of Boule Diagnostics AB's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Boule Diagnostics AB (OSTO:BOUL) Business Description

Traded in Other Exchanges
N/A
Address
Domnarvsgatan 4, Spanga, SWE, SE-163 53
Boule Diagnostics AB is a company operating in the diagnostics market. It is engaged in the development, manufacturing and marketing instruments and consumables for blood diagnostics. The firm focuses on the decentralized market segment. The systems are intended for small and medium-sized hospitals, clinics and laboratories within outpatient care. Through its subsidiaries, the Group operates in Sweden, USA, and China.

Boule Diagnostics AB (OSTO:BOUL) Headlines

No Headlines